ArticleNeurological research and practice2024

Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS study.

Antonios Bayas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.